BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34693462)

  • 1. The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study.
    Mazzucchi E; Vollono C; Pauletto G; Lettieri C; Budai R; Gigli GL; Sabatino G; La Rocca G; Skrap M; Ius T
    J Neurol; 2022 May; 269(5):2627-2633. PubMed ID: 34693462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
    J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse low grade glioma after the 2016 WHO update, seizure characteristics, imaging correlates and outcomes.
    Roberts M; Northmore T; Shires J; Taylor P; Hayhurst C
    Clin Neurol Neurosurg; 2018 Dec; 175():9-15. PubMed ID: 30292978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Aghi MK; Nahed BV; Sloan AE; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):503-30. PubMed ID: 26530265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma.
    Choi J; Kim SH; Ahn SS; Choi HJ; Yoon HI; Cho JH; Roh TH; Kang SG; Chang JH; Suh CO
    Sci Rep; 2020 Feb; 10(1):2086. PubMed ID: 32034238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With
    Bruno F; Pellerino A; Conti Nibali M; Pronello E; Cofano F; Rossi M; Levis M; Bertero L; Soffietti R; Cassoni P; Garbossa D; Bello L; Rudà R
    Neurology; 2024 May; 102(10):e209352. PubMed ID: 38684041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
    Yao PS; Zheng SF; Wang F; Kang DZ; Lin YX
    J Neurosurg; 2018 Mar; 128(3):840-845. PubMed ID: 28387627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures in patients with IDH-mutated lower grade gliomas.
    Carstam L; Rydén I; Jakola AS
    J Neurooncol; 2022 Nov; 160(2):403-411. PubMed ID: 36258151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
    Chang EF; Potts MB; Keles GE; Lamborn KR; Chang SM; Barbaro NM; Berger MS
    J Neurosurg; 2008 Feb; 108(2):227-35. PubMed ID: 18240916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy surgery related to pediatric brain tumors: Miami Children's Hospital experience.
    Fallah A; Weil AG; Sur S; Miller I; Jayakar P; Morrison G; Bhatia S; Ragheb J
    J Neurosurg Pediatr; 2015 Dec; 16(6):675-80. PubMed ID: 26339959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.
    Morshed RA; Han SJ; Hervey-Jumper SL; Pekmezci M; Troncon I; Chang SM; Butowski NA; Berger MS
    J Neurooncol; 2019 Jan; 141(2):383-391. PubMed ID: 30498891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.
    Still MEH; Roux A; Huberfeld G; Bauchet L; Baron MH; Fontaine D; Blonski M; Mandonnet E; Guillevin R; Guyotat J; Taillandier L; Capelle L; Duffau H; Pallud J
    Neurosurgery; 2019 Aug; 85(2):E332-E340. PubMed ID: 30395304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of Seizure Freedom After Surgical Resection of Diffuse Low-Grade Gliomas.
    Bonney PA; Boettcher LB; Burks JD; Baker C; Conner AK; Fujii T; Mehta VA; Briggs RG; Sughrue ME
    World Neurosurg; 2017 Oct; 106():750-756. PubMed ID: 28673890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
    Wijnenga MMJ; French PJ; Dubbink HJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Smits M; Gahrmann R; Rutten GJ; Verheul JB; Fleischeuer R; Dirven CMF; Vincent AJPE; van den Bent MJ
    Neuro Oncol; 2018 Jan; 20(1):103-112. PubMed ID: 29016833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors associated with the surgical efficacy and prognosis of seizures in patients with low-grade glioma].
    Fang F; Lin YX; Kang DZ; Wang F; Huang XF; Yu LH; Lin ZY
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1031-4. PubMed ID: 27055796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
    J Neurosurg; 2019 Feb; 132(2):518-529. PubMed ID: 30717057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas.
    Bono BC; Ninatti G; Riva M; Raspagliesi L; Barbieri EM; Navarria P; Clerici E; Politi LS; Simonelli M; Rodari M; Sollini M; Chiti A; Pessina F
    Neurosurg Focus; 2024 Feb; 56(2):E6. PubMed ID: 38301247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical, functional, and oncological considerations regarding awake resection for giant diffuse lower-grade glioma of more than 100 cm3.
    Sauvageot S; Boetto J; Duffau H
    J Neurosurg; 2023 Oct; 139(4):934-943. PubMed ID: 36964732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
    Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
    World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.